GRND · Grindr Inc. · Stock research

Current Thesis

Grindr's re-rating story is the product-led monetization pivot — average paying users and price-per-user rising together, layered with two new revenue engines (the EDGE ultra-premium tier and the Woodwork telehealth brand). The thesis is intact but the momentum leg has cooled. Shares peaked near $20 in spring 2026, pulled back, bounced on Morgan Stanley's 2026-07-01 Overweight upgrade to $15.69 (2026-07-10), then faded to $14.85 (2026-07-24) — drifting back toward the rising moving-average cluster rather than extending. Everything now funnels into a single binary: the Q2 2026 print after the close on 2026-08-06, which must clear a guidance bar management already raised on 2026-05-07. The clean version of this trade is a pullback that holds the 50-/200-day cluster and turns, not a chase into the print.

Bullish and bearish views on Grindr Inc.

The model's bull view on Grindr Inc. (GRND), in brief: Beat-and-raise with margin proof (2026-05-07): Q1 2026 revenue $130M, +38% YoY vs $121.7M consensus; adjusted EBITDA $58M at a 45% margin; net income $27M. The bear view: The upgrade bounce already reversed: shares ran to a spring high near $20 ($19.58–$20.10 trailing 52-week high), gave back the move, bounced to $15.69 on the 2026-07-01 note, then slid to $14.85 by 2026-07-24. Both cases follow in full.

Bull Case

• Beat-and-raise with margin proof (2026-05-07): Q1 2026 revenue $130M, +38% YoY vs $121.7M consensus; adjusted EBITDA $58M at a 45% margin; net income $27M. App revenue $107M, advertising $23M. Full-year guide lifted to at least $535M revenue / $227M adjusted EBITDA. This is a GAAP-profitable subscription cash engine.
• Both pricing levers firing (Q1 2026): Average Paying Users +19% YoY and ARPPU +12% to $25.63 — raising price without bleeding users, the hard part of any subscription network.
• Second and third revenue engines (Morgan Stanley, 2026-07-01, analyst Nathan Feather): EDGE ultra-premium tier at $100–500/month (an Australia test near $80/month showed strong demand); Woodwork telehealth (ED treatment, GLP-1, peptides) projected at ~$28M revenue by 2028, with ~30% of users already on ED medication. MS models EDGE plus Woodwork as roughly 60% of revenue growth through 2028.
• Valuation vs growth (MS, 2026-07-01): ~23% revenue growth modeled for 2026 and ~17% for 2027 on ~11x 2027 EBITDA; Overweight, $18 target. Street consensus target ~$18.80 with 5 buys and 0 sells as of mid-July 2026.
• Buyback under the price: management repurchased over $100M of stock across December 2025 and Q1 2026, and short interest at ~27% (finviz, 2026-07-10) is covering fuel into any upside surprise.

Bear Case

• The upgrade bounce already reversed: shares ran to a spring high near $20 ($19.58–$20.10 trailing 52-week high), gave back the move, bounced to $15.69 on the 2026-07-01 note, then slid to $14.85 by 2026-07-24. Price is fading into the catalyst, so the tape is repairing rather than accelerating.
• Elevated bar into 2026-08-06: the full-year guide was already raised on 2026-05-07, so the Q2 print has to clear a lifted setup; any deceleration in paying users or ARPPU gets punished from a mid-range price.
• The big catalyst is an out-year story: MS frames EDGE as a late-2026/early-2027 launch and Woodwork's $28M as a 2028 number — the premium-tier revenue is not a near-term print driver, so the re-rating leans on out-year execution the market has to underwrite on faith.
• EDGE pricing is unproven at scale: the $100–500/month band rests on one small Australia test near $80/month; broad willingness-to-pay in that range is a bet, not a datapoint.
• minor on its own, but the controlled register (San Vicente Acquisition) remains a rally cap, and app-store dependency plus content-moderation and privacy scrutiny are permanent tail risks.

Setup & Price Structure

Shares closed $14.85 on 2026-07-24, down from $15.69 on 2026-07-10, drifting toward a rising 50-day SMA near $13.5–14 and a 200-day SMA near $13. The buffer above the 50-day has compressed from roughly 17% in early July to high single digits, and the RSI that sat near 68 on 2026-07-10 has cooled back toward neutral. The intermediate uptrend is still intact with both averages rising beneath price, but the impulse from the July upgrade is spent — this is a maturing move settling into a range, mid-way inside a $9.73–$20 annual band. The constructive path is a base build near the moving-average cluster that holds through the 2026-08-06 print; the destructive path is a break of $13 that forfeits the June recovery structure. For a maturing theme like this one, the disciplined entry is a pullback that holds support and turns higher on volume, and fresh exposure ahead of a binary earnings date carries the full gap risk.

Catalyst Calendar (next 30 days)

• EDGE ultra-premium tier (undated, MS: late-2026/early-2027): a firm pricing and launch-timing disclosure would be standalone narrative fuel independent of earnings, but nothing is scheduled inside the next 30 days.
• Woodwork telehealth (undated): any rollout metric or partnership update is an unscheduled add-on to the story.
• Form 4 monitoring: any San Vicente secondary or clustered insider sales on a rally toward the $18–20 zone.

Elapsed catalysts

• 2026-08-06 (confirmed): Q2 2026 results after the close; conference call 2:00 p.m. PT / 5:00 p.m. ET. This is the dominant near-term event and the entire setup pivots on it. It enters the 3-trading-day binary-risk window around 2026-08-03 — stand aside into the print unless already positioned on a clean base. (passed 3d ago)
• Analyst clustering: watch for follow-on ratings behind Morgan Stanley (2026-07-01, OW $18); consensus target ~$18.80 as of mid-July 2026. (passed 39d ago)

What Would Change Our Mind

• Structural break: a weekly close below $13 forfeits the rising 50-/200-day SMA cluster and the June recovery base — the re-rating structure is gone and the name reverts to a range-bound value question; stand aside.
• Fundamental break: a 2026-08-06 print showing paying-user or ARPPU deceleration, a full-year guidance cut, or adjusted-EBITDA margin slipping meaningfully below the ~45% Q1 line — the "both levers firing" thesis fails and the multiple compresses.
• Catalyst break: EDGE priced or received well below the promised $100–500/month band, or the launch slipping deeper into 2027 with no interim proof point — the second revenue engine loses credibility.
• Confirmation that would raise conviction: a clean beat-and-raise on 2026-08-06 that holds paying-user growth in the high teens and positive ARPPU, plus a firm EDGE price at or above the band, with price reclaiming $16–17 on expanding volume and short covering — that flips the read from maturing to accelerating and becomes a setup to size.

Correlation Notes

• Theme: consumer-discretionary-rotation, read as MATURING (2026-07-12). Trades with risk-on discretionary appetite; a macro-tightening turn pressures higher-multiple subscription names first.
• Dating/social peers: MTCH (Match Group) and BMBL (Bumble). GRND's differentiator is demonstrated pricing power; a weak engagement or subscription-revenue print from MTCH or BMBL would get read across to GRND's "raise price without losing users" narrative regardless of GRND's own trajectory.
• Telehealth read-through: Woodwork ties a small correlation to HIMS (Hims & Hers) on GLP-1 and ED demand trends.
• Idiosyncratic driver: ~27% short interest means single-stock, news-driven two-way volatility that decouples from index beta; the 2026-08-06 print dominates correlation over the next month.
• Cap/beta: ~$2.64B market cap places it in the small/mid-cap growth cohort, sensitive to rate and liquidity swings, though its GAAP profitability cushions the multiple relative to cash-burning peers.